Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
加載中

CRITICISM of Everpride Biopharmaceutical Company Limited (Stock Code: 8019) for delay in publication and despatch of its annual results and annual report for the year ended 31 December 2005 and of its first quarterly report for the period ended 31 March 2006, and for providing insufficient notice of the board meetings held on 4 May 2006 and 15 May 2006

所選語言不存在